 Recent advancements in RNA-based therapeutics have opened up a new era of drug discovery and development. Small biotechnology companies and academic researchers alike have been able to quickly develop novel RNA constructs for treating a variety of diseases. Additionally, these drugs are cost-effective, easy to manufacture and can target previously untreatable pathways. As a result, RNA-based therapeutics are poised to revolutionize the way we treat disease. This article was authored by Tulsi Ramdamase, Roman Sikovershin, Christian Boda, and others.